Extracorporeal Photopheresis : : Cellular Photoimmunotherapy / / ed. by Hildegard T. Greinix, Robert Knobler.

Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer, namely cutaneous T-cell lymphoma, and has demonstrated efficacy in various diseases that have a suspected involvement of pathogenic T-cells including prevention and treatment of acute and chronic gra...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter DGBA Backlist Complete English Language 2000-2014 PART1
MitwirkendeR:
HerausgeberIn:
Place / Publishing House:Berlin ;, Boston : : De Gruyter, , [2012]
©2012
Year of Publication:2012
Language:English
Online Access:
Physical Description:1 online resource (215 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Preface
  • Content
  • Authors Index
  • Section 1: History of Extracorporeal Photopheresis
  • Section 2: Technical Aspects
  • Section 3: Mechanisms of Action of ECP
  • Section 4: Extracorporeal Photopheresis in Acute Graft-versus-Host Disease
  • Section 5: Extracorporeal Photopheresis in Chronic Graft-versus-Host Disease
  • Section 6: ECP for the Prevention of Graft-versus-Host Disease
  • Section 7: ECP in Cutaneous T Cell Lymphoma
  • Section 8: ECP in Scleroderma and Other Skin Diseases
  • Section 9: ECP in Crohn's Disease
  • Section 10: Extracorporeal Photopheresis after Solid Organ/Tissue Transplantation
  • Section 11: ECP in Diabetes Mellitus
  • Section 12: Side Effects of Extracorporeal Photopheresis
  • Section 13: Summary